THE LOAN RANGER
Business Today India|December 11, 2022
RIDING ON THE OVERALL GROWTH IN CREDIT AND ROBUST ASSET QUALITY, HDFC BANK HAS EMERGED AS THE TOP LENDER ON THE BT500 2022 LIST. BUT EVEN AS ANALYSTS ARE BULLISH ABOUT THE SECTOR HEAVYWEIGHT, ITS STOCK SEEMS TO BE UNDER PRESSURE
ASHISH RUKHAIYAR
THE LOAN RANGER

A LARGE BALANCE sheet. Strong net worth. Complementary strengths. These are factors that generally excite both market analysts and investors. But strangely enough, they didn’t work for HDFC Bank if its stock price is any indication. Despite that, HDFC Bank is once again the top-ranked lender in this year’s BT500 list—based on the average market cap during the October 2021-September 2022 period.

But let’s start at the beginning. On April 4, 2022, HDFC Bank (No. 3 on the BT500 2022 list) announced that housing finance major HDFC Ltd will be merged into the bank to create an entity “that would allow greater flow of credit into the economy”. This didn’t come as a surprise as the move was widely expected in banking circles. Yet, since April 4, shares of HDFC Bank have lost around 2.6 per cent (till November 18) while the benchmark S&P BSE Sensex has gained 1.74 per cent. The S&P BSE Bankex—the sectoral barometer for banks—is also up 10.16 per cent in the same period, indicating that most banks had a good run on the bourses since April this year.

But for HDFC Bank, the past two years have been rough as its stock underperformed the Sensex by a wide margin. For instance, the Sensex was up nearly 30 per cent in 2021 while HDFC Bank’s shares clocked gains of just 3 per cent. That’s not to say that HDFC Bank—incorporated in August 1994 and which, as on June 30, had nearly 6,500 branches and 19,000 ATMs across 3,226 towns or cities—is a perennial laggard. As recently as 2019, its shares had gained nearly 20 per cent when the Sensex had moved up by around 15 per cent. And that wasn’t the only time when its stock outperformed the BSE in a calendar year.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM BUSINESS TODAY INDIAView all
REACHING FOR THE COUNTERS
Business Today India

REACHING FOR THE COUNTERS

DESPITE HEALTH CONCERNS, THE INCREASING POPULARITY OF OTC DRUGS HAS LED TO PHARMA MAJORS SEIZING THE CHANCE TO DIVERSIFY THEIR REVENUE STREAMS. THE RISING POPULARITY OF SKINCARE AND PERSONAL HEALTH HAS LED TO EASY ACCESS OF SEVERAL DERMATOLOGICAL PRODUCTS. FROM D2C BRANDS TO ESTABLISHED PLAYERS, PHARMA COMPANIES ARE LOOKING TO BITE INTO THE PIE

time-read
7 mins  |
March 02, 2025
the art of time
Business Today India

the art of time

THE SIXTH EDITION OF THE LVMH WATCH WEEK WAS HELD IN NEW YORK AND PARIS RECENTLY. WE LOOK AT SOME OF THE LATEST CREATIONS SHOWCASED

time-read
2 mins  |
March 02, 2025
Celestial Disruption
Business Today India

Celestial Disruption

ASTROLOGY, OR THE STUDY OF THE FUTURE FORETOLD BY CELESTIAL BODIES, IS EXPERIENCING A COSMIC TRANSFORMATION, FUELLED BY DIGITAL DISRUPTION, ARTIFICIAL INTELLIGENCE, AND A $7-BILLION FAITH MARKET

time-read
10 mins  |
March 02, 2025
"MANUFACTURING HAS MOVED TO THE FOREFRONT"
Business Today India

"MANUFACTURING HAS MOVED TO THE FOREFRONT"

Rahul Jain, BCG India Head, on the future of manufacturing, how India can capitalise on global trends and more

time-read
6 mins  |
March 02, 2025
"Reignite the spirit of ownership"
Business Today India

"Reignite the spirit of ownership"

Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company

time-read
1 min  |
March 02, 2025
TRICITY TRIUMPHS
Business Today India

TRICITY TRIUMPHS

CHANDIGARH, MOHALI & PANCHKULA DELIVERED SOME OF THE LONGEST DRIVES THIS SEASON

time-read
2 mins  |
March 02, 2025
"AIM TO TRIPLE PROFITS TO ₹2,500 CRORE BY FY28”
Business Today India

"AIM TO TRIPLE PROFITS TO ₹2,500 CRORE BY FY28”

Anand Roy, MD and CEO of Star Health Insurance, on the future of the company, challenges in the health insurance sector, and more

time-read
6 mins  |
March 02, 2025
WHITHER THE RUPEE?
Business Today India

WHITHER THE RUPEE?

THE RUPEE HAS DECLINED SHARPLY ALONG WITH OTHER CURRENCIES AS THE DOLLAR HAS STRENGTHENED AFTER DONALD TRUMP TOOK OFFICE AS THE PRESIDENT OF THE US. WILL THE RUPEE CONTINUE TO DEPRECIATE AND WHAT WILL THE IMPACT BE ON INDIA'S ECONOMY?

time-read
10+ mins  |
March 02, 2025
"Some of our states have to introspect and get their act together"
Business Today India

"Some of our states have to introspect and get their act together"

Finance Minister Nirmala Sitharaman on the measures announced in the recent Budget, India's growth prospects, global uncertainty and more

time-read
10 mins  |
March 02, 2025
ZOMATO REBRANDED: More Than Just Delivery
Business Today India

ZOMATO REBRANDED: More Than Just Delivery

With Blinkit growing rapidly, renaming Zomato to Eternal drives home the multifaceted nature of business

time-read
3 mins  |
March 02, 2025